Krishna Pachipala

SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer

Hossein Borghaei, Filippo de Marinis, Daphne W. Dumoulin et al. · Annals of Oncology · 2023 · 93 citations · Full text

Medicine, Oncology, Pharmacology +13

Phase III trial of sitravatinib plus nivolumab vs. docetaxel for treatment of NSCLC after platinum-based chemotherapy and immunotherapy (SAPPHIRE).

Ivor Percent, Craig H. Reynolds, Kartik Konduri et al. · Journal of Clinical Oncology · 2020 · 13 citations

Medicine, Oncology, Pharmacology +17

Small-Cell Cancers, and an Unusual Reaction to Chemotherapy

Ion D. Bucaloiu, Srinivasan Dubagunta, Krishna Pachipala et al. · Journal of Clinical Oncology · 2003 · 10 citations

Medicine, Oncology, Chemotherapy +8

Effect of trilaciclib, a CDK 4/6 inhibitor, on myelosuppression in patients with previously treated extensive-stage small cell lung cancer receiving topotecan.

Lowell L. Hart, Zoran Andrić, Maen Hussein et al. · Journal of Clinical Oncology · 2019 · 10 citations

Medicine, Oncology, Pharmacology +9